MYOD1 and medulloblastoma: This issue might be relevant, as MYOD has been reported to exert tumor suppressor functions in numerous tissues involving FOXP2 mutation: MYOD exerts anti-proliferative actions, and is suspected to play a tumor suppressor role in breast cancer cells [151], as well as in medulloblastoma [152], and in rhabdomyosarcoma of the prostate [153].